CD8A and neoplasm: These results imply that NAT10 may promote the increase of KRT8 ligands in tumor epithelial cells through ac4C acetylation and bind to the corresponding receptors on CD8 + T cells, consequently enhancing the interaction between tumor cells and CD8 + T cells and ultimately suppressing the immune microenvironment.